TR201905240T4 - Humanized antibodies to LIV-1 and their use in the treatment of cancer. - Google Patents

Humanized antibodies to LIV-1 and their use in the treatment of cancer. Download PDF

Info

Publication number
TR201905240T4
TR201905240T4 TR2019/05240T TR201905240T TR201905240T4 TR 201905240 T4 TR201905240 T4 TR 201905240T4 TR 2019/05240 T TR2019/05240 T TR 2019/05240T TR 201905240 T TR201905240 T TR 201905240T TR 201905240 T4 TR201905240 T4 TR 201905240T4
Authority
TR
Turkey
Prior art keywords
liv
treatment
humanized antibodies
cancer
antibodies
Prior art date
Application number
TR2019/05240T
Other languages
Turkish (tr)
Inventor
Leia Smith Maria
Sussman Django
Arthur William
Nesterova Albina
Original Assignee
Seattle Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seattle Genetics Inc filed Critical Seattle Genetics Inc
Publication of TR201905240T4 publication Critical patent/TR201905240T4/en

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

Mevcut buluş, LIV-1'e spesifik olarak bağlanan hümanize antikorlar sağlamaktadır. Antikorlar, LIV-1'i tespit etmenin yanı sıra, çeşitli kanserlerin tedavisi ve teşhisi için faydalıdır.The present invention provides humanized antibodies that specifically bind to LIV-1. In addition to detecting LIV-1, antibodies are useful for the treatment and diagnosis of various cancers.

TR2019/05240T 2011-02-25 2011-12-06 Humanized antibodies to LIV-1 and their use in the treatment of cancer. TR201905240T4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161446990P 2011-02-25 2011-02-25
US201161420291P 2011-02-25 2011-02-25

Publications (1)

Publication Number Publication Date
TR201905240T4 true TR201905240T4 (en) 2019-05-21

Family

ID=67953945

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/05240T TR201905240T4 (en) 2011-02-25 2011-12-06 Humanized antibodies to LIV-1 and their use in the treatment of cancer.

Country Status (1)

Country Link
TR (1) TR201905240T4 (en)

Similar Documents

Publication Publication Date Title
CY1123883T1 (en) HUMANIZED ANTIBODIES TO LIV-1 AND THEIR USE FOR THE THERAPEUTIC TREATMENT OF CANCER
CY1122490T1 (en) ANTIBODIES TO HUMAN CD38
CY1122091T1 (en) CD37-BINDING MOLECULES AND IMMUNOCONJUGUES THEREOF
MX2014009751A (en) Antibodies to integrin avvb6 and use of same to treat cancer.
EA201390472A1 (en) NEW MOLECULES CONNECTING WITH EGFR AND THEIR IMMUNOCONJUGATES
CY1118668T1 (en) Immunoconjugates Against Folic Acid Receptors 1 and their uses
EA201490717A1 (en) ANTIBODIES TO ErbB3 AND THEIR APPLICATION
PH12014501164A1 (en) Anti-cd98 antibodies and methods of use thereof
TN2015000396A1 (en) Antibody drug conjugates
EA201591611A1 (en) CONJUGATES ANTIBODY AND MEDICINE
EA201390575A1 (en) NON-ANTAGONISTIC EGFR-BINDING MOLECULES AND THEIR IMMUNOCONJUGATES
EA201590174A1 (en) IMMUNOCONGATES CONTAINING ANTI-CD22 ANTIBODIES
EA201291039A1 (en) HUMAN CD27 ANTIBODIES AND THEIR APPLICATION
EA201790664A1 (en) ANTIBODIES AGAINST MEZOTELINE AND IMMUNOCONJUGATES
EA201492137A1 (en) ANTIBODIES TO CD33 AND THEIR APPLICATION IN CANCER TREATMENT
EA201391507A1 (en) ANTIBODIES AGAINST c-Kit AND THEIR APPLICATION
EA201291260A1 (en) ANTIBODY AGAINST TROP-2 PERSON HAS ANTI-TUMOR ACTIVITY IN VIVO
EA201490778A1 (en) ANTIBODIES AGAINST HtrA1 AND METHODS OF APPLICATION
EA201201000A1 (en) METHODS OF TREATMENT OF COLORECTAL CANCER
EA201200999A1 (en) METHODS OF TREATMENT BREAST CANCER
CY1122156T1 (en) ANTIBODIES TO KIDNEY-ASSOCIATED ANTIGEN 1 AND ANTIGEN-BINDING FRAGMENTS THEREOF
EA201490180A1 (en) ANTIBODIES TO ERBB3 IN COMBINATION WITH PAKLITAXEL FOR THE TREATMENT OF GYNECOLOGICAL MALIGNANT DISEASES
MX2013002718A (en) Anti-vegfr-3 antibody compositions.
TR201905240T4 (en) Humanized antibodies to LIV-1 and their use in the treatment of cancer.
TN2013000068A1 (en) Anti-vegfr-3 antibody compositions